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ORIGINAL ARTICLE 
 
EVALUATION OF DRUG RELEASE KINETICS 
FROM IBUPROFEN MATRIX TABLETS USING HPMC 
 
M. HARRIS SHOAIB*, JAWERIA TAZEEN, HAMID A. MERCHANT 
AND RABIA ISMAIL YOUSUF 
Department of Pharmaceutics, Faculty of Pharmacy, University of Karachi, 
Karachi-75270, Pakistan 
 
ABSTRACT 
The aim of this study is to develop a once-daily sustained release matrix tablet of ibuprofen using hydroxypropyl 
methylcellulose (HPMC) as release controlling factor and to evaluate drug release parameters as per various release 
kinetic models. In order to achieve required sustained release profile tablets were directly compressed using Avicel 
pH 101 and Magnesium stearate.  The formulated tablets were also characterized by physical and chemical 
parameters and results were found in acceptable limits. Different dissolution models were applied to drug release 
data in order to evaluate release mechanisms and kinetics. Criteria for selecting the most appropriate model was 
based on linearity (coefficient of correlation).  The drug release data fit well to the Higuchi expression. Drug release 
mechanism was found as a complex mixture of diffusion, swelling and erosion.  
 
Keywords: Ibuprofen; sustained release; hydrophillic matrix; HPMC; direct compression. 
 
INTRODUCTION  
 
In chronic inflammatory diseases like rheumatoid arthritis, 
ankylosing spondylitis, osteoarthritis and other non-
rheumatoid arthropathies treatment is usually prolong and 
large doses are required (Dollery, 1999). Ibuprofen a 
phenylpropionic acid derivative is established as first-line 
NSAID for rheumatoid arthritis and chronic arthropathies. 
The mechanism of action of ibuprofen involves not only 
inhibition of prostaglandin synthesis but also decreased 
production of pro-inflammatory cytokines such as 
interleukin 1β and tumour necrosis factor α; inhibition of 
leucocyte leucotriene B4 and nitric oxide; and possibly a 
positive effect on the production of oxyradicals and 
signaling transduction via the NFțB pathway. In therapeutic 
use, ibuprofen proved to have a favourable risk: benefit ratio 
and predictable adverse effects (Rainsford, 2002). Thus for 
patient compliance, improve bioavailability, minimize total 
drug quantity, minimize accumulation on chronic use and 
reduce fluctuation in drug level sustained release of 
ibuprofen is desirable. 
 
Hydrophillic polymer matrix systems are widely used in 
oral controlled drug delivery systems because of their 
flexibility to obtain a desirable drug release profile, cost 
effectiveness, and broad regulatory acceptance (Lordi, 
1986). Drug release from hydrophillic matrices is known to 
be a complex interaction between dissolution, diffusion and 
erosion mechanisms.  Hydroxypropyl methylcellulose 
(HPMC) is the first choice for formulation of hydrophillic 
matrix system, providing robust mechanism, choice of 
viscosity grades, nonionic nature, consistent reproducible 
release profiles, cost effectiveness and utilization of existing 
conventional equipment and methods (Colorcon, 2005). 
Water penetration, polymer swelling, drug dissolution, drug 
diffusion and matrix erosion from dosage form is controlled 
by the hydration of HPMC, which forms the gel barrier 
through which the drug diffuses (Sung et al., 1996). 
 
Direct compression was used to compress the tablets, as 
keeping in mind that HPMC is a hydrophillic polymer that 
swells to a significant extent upon contact with water.  
Various studies of drug release mechanism, effect of 
formulation variables on HPMC matrices are based on 
direct compression (Somade and Singh, 2002; Sung et al., 
1996). 
 
Several mathematical models have been published, to 
elucidate the water and drug transport processes and to 
predict the resulting drug release kinetics (Korsmeyer et al., 
1986a,b; Cohen and Erneux, 1988a,b; Gao et al., 1995; Ju et 
al., 1995; Siepmann et al., 1999a,b). The mathematical 
description of the entire drug release process is rather 
difficult, because of the number of physical characteristics 
that must be taken into consideration. These include the 
diffusion of water into the HPMC matrix, HPMC swelling, 
drug diffusion out of the device, polymer dissolution, axial 
and radial transport in a 3-dimensional system, conc-
entration dependent diffusivities of the species, moving 
boundaries, and changing matrix dimensions, porosity and 
composition. Each model makes certain assumptions and 
due to these assumptions, the applicability of the respective 
models is restricted to certain drug–polymer systems 
(Siepmann et al., 2000). 
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The aim of this work was to prepare uncoated hydrophillic 
matrix tablets containing ibuprofen as a model drug, and 
HPMC as hydrophillic matrix to retard drug release. 
Ibuprofen used as 800mg per tablet and  2 tablets will be 
indicated as a single dose which will maintain the required 
plasma level of ibuprofen for 24 hrs.(Data sheet, 2005). 
Ibuprofen was directly compressed with HPMC along with 
release modifier (microcrystalline cellulose) and lubricant 
(magnesium stearate) into caplet. The manufacturing 
process was validated against pre-defined acceptance 
criteria on three experimental batches.  In vitro dissolution 
studies were performed on formulation along with various 
other usual testing. Another objective of this work is to 
evaluate drug release data using various kinetic models and 
to determine the mechanism of drug release.  
 
MATERIALS AND METHODS 
 
Materials 
The following materials were used: Ibuprofen (Himont 
Chemicals, Lahore, Pakistan) a gift from Efroze Chemical 
Industries, HPMC 4000cps (USP Type-2208) (Dow 
Chemicals, USA), Avicel PH-101 (FMC Corporation, 
USA), magnesium stearate (Merck KgaA, Darmstadt, 
Germany) were obtained and used as received.  All other 
chemicals used were of analytical grade. 
 
Preparation of tablets 
Experimental batches of 1.2Kg each were prepared by direct 
compression having ibuprofen (66.67%), HPMC (20.00%), 
Avicel PH-101 (12.33%) and magnesium stearate (1.0%). 
Mixing of powders was performed by geometric dilution 
method in polythene bag.  Then this blend was compressed 
with manually operated single-punch tablet machine 
(KORSCH Erweka, Frankfurt, Germany), using 19.0mm 
length, 8.8mm breadth caplet shaped concave punches with 
a target compression weight of 1.2g/tab containing 800mg 
active so as to achieve two tablets once daily as a single 
dose. 
 
Evaluation of tablets 
Tablets were subjected to various physical tests which 
include weight variation (Mettler Toledo B204-S, 
Switzerland), thickness, length & breadth, hardness (OSK 
Fujiwara Hardness Tester, Tokyo, Japan), friability 
(Friabilator, H.Jurgens GmbH & Co., Bremen, Germany) as 
per BP official methods. In vitro release study was 
performed using USP <711> apparatus type II at 50 rpm 
(Erweka DT700, Husenstamm, Germany). The dissolution 
medium used was 900 ml phosphate buffer pH 7.2 for 12 
hrs; maintained at 37 ± 0.5°C. The drug release was 
evaluated by taking sample of 10 ml (which were replaced 
with fresh medium) at predetermined time intervals and 
absorbance was measured (Ȝ = 221nm) after filtration and 
suitable dilution (UV Spectrophotometer 150-02, Shimadzu 
Corporation, Kyoto, Japan). Drug content was analyzed 
using HPLC (LC-5A, SPD-2A, Shimadzu Corporation, 
Kyoto, Japan) as per official method of ibuprofen (BP, 
2004). 
 
Process validation 
Experimental batches were validated to confirm the 
accuracy and reproducibility of physical and chemical 
characteristics. Mixing time was validated by performing 
content uniformity tests for ibuprofen in the blend at three 
stages of the mixing time of one hour i.e., 75%, 85% and 
100% of the mixing time. While compression; hardness, 
thickness and weight variation was evaluated and data was 
compared for all three batches. In vitro release profile and 
assay results were also evaluated and compared with pre-
defined criteria.  
 
Data analysis 
To analyze the in vitro release data various kinetic models 
were used to describe the release kinetics. The zero order 
rate Eq. (1) describes the systems where the drug release 
rate is independent of its concentration (Hadjiioannou et al., 
1993). The first order Eq. (2) describes the release from 
system where release rate is concentration dependent 
(Bourne, 2002). Higuchi (1963) described the release of 
drugs from insoluble matrix as a square root of time 
dependent process based on Fickian diffusion Eq. (3). The 
Hixson-Crowell cube root law Eq. (4) describes the release 
from systems where there is a change in surface area and 
diameter of particles or tablets (Hixson and Crowell, 1931). 
 
C = kot                              (1) 
 
Where, K0 is zero-order rate constant expressed in units of 
concentration/time and t is the time. 
303.2/ktLogCLogC o −=  (2) 
 
Where, C0 is the initial concentration of drug and K is first 
order constant. 
 
2/1KtQ =  (3) 
 
Where, K is the constant reflecting the design variables of 
the system. 
 
Q0
1/3 – Qt
1/3 = KHC t (4) 
 
Where, Qt is the amount of drug released in time t, Q0 is the 
initial amount of the drug in tablet and KHC is the rate 
constant for Hixson-Crowell rate equation. 
 
The following plots were made: cumulative % drug release 
vs. time (zero order kinetic model); log cumulative of % 
drug remaining vs. time (first order kinetic model); 
cumulative % drug release vs. square root of time (higuchi 
model) log cumulative % drug release vs. log time 
(korsmeyer model) and cube root of drug % remaining in 
matrix vs. time (hixson-crowell cube root law).  
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Mechanism of drug release 
Korsmeyer et al (1983) derived a simple relationship which 
described drug release from a polymeric system Eq. (5). To 
find out the mechanism of drug release, first 60% drug 
release data was fitted in Korsmeyer–Peppas model: 
 
n
t KtMM =∞/  (5) 
 
Where Mt / M∞ is fraction of drug released at time t, k is the 
rate constant and n is the release exponent. The n value is 
used to characterize different release mechanisms as given 
in table 1 for cylindrical shaped matrices. 
 
Table 1: Diffusion exponent and solute release mechanism 
for cylindrical shape 
 
Diffusion 
exponent (n) 
Overall solute diffusion mechanism 
0.45 Fickian diffusion 
0.45 < n < 0.89 Anomalous (non-Fickian) diffusion 
0.89 Case-II transport 
n > 0.89 Super case-II transport 
 
RESULTS AND DISCUSSION 
 
Preparation and evaluation of matrix tablets 
Tablets were compressed without any problem and do not 
require any change in ratio of excipient in formulation. 
Tablets prepared were smooth, shiny and do not require 
coating as for experimental purpose (for patient compliance 
and palatability aqueous polymer coating can be 
performed). Weight variation was within limit of ±5% and 
hardness was also set at 16.00 kg ±5kg. Actual values are 
given in table 2. Length and breadth was found fixed as per 
punch size and thickness was controlled as well to an 
average of 9.18mm and S.D. was found as little as 0.0131. 
By holding the tablet weight and thickness constant, the 
surface area and volume were essentially fixed. All tablets 
contained 800mg ± 5% (66.67% w/w) of Ibuprofen as 
confirmed by assay procedure. Mean drug content value 
obtained was 98.40% (S.D. of 2.3193) which was found 
satisfactorily within limits.   
 
In-vitro dissolution studies and duration of release 
For the controlled release under investigation, which is a 
matrix-tablet comprising drug, and hydrophillic polymer, 
the release should follow three steps. First step is the 
penetration of the dissolution medium in the tablet matrix 
(hydration). Second step is the swelling with concomitant or 
subsequent dissolution or erosion of the matrix and third 
step is the transport of the dissolved drug, either through the 
hydrated matrix or from the parts of the eroded tablet, to the 
surrounding dissolution medium (Kiortsis et al., 2005). The 
ibuprofen released at first hour was 45.30%, 43.1% and 
47.2%; at 6h 70.92%, 69.10% and 73.02%; and at 12h drug 
release was 89.23%, 88.10% and 89.15% respectively for 
three experimental batches. For predictive completion of 
release the drug release data of ibuprofen obtained from 
dissolution is plotted as concentration (mg/L) vs. time (h). 
The straight line indicates zero order in accordance with Eq. 
1. Linear regression analysis of the data yields the equation 
of best line as c = 35.59t + 390.32 and R2 = 0.9672. 
According to Eq. 1 , the slope of line corresponds to the 
zero order rate constant. Therefore rate of dissolution is k0  = 
35.59 mgL-1 h-1. The rate of release in terms of amount of 
ibuprofen dissolved or released per unit time can be 
obtained as: 
 
k0  x V  (6) 
 
where V is volume of dissolution medium (L).  
 
 
Table 2: Physical and chemical parameters of formulated ibuprofen tablets 
 
Weight Variation (%) 
n = 20 
Thickness  
(mm) 
n = 20 
Friability 
(%) 
n = 10 
Hardness  
(Kg) 
n = 20 
Drug content  
(%) 
n = 2 
Mean = 1.2209mg  
+ 2.71%, - 3.84% 
S.D = 0.0040 
Mean = 91.8 
+ 4 mm, – 2 mm 
S.D = 0.0131 
0.0664  
Mean = 16.87 
+ 4.7 kg, - 5.57 kg 
S.D = 2.9420 
Mean = 98.40 
S.D = 2.3193 
 
S.D = Standard Deviation, + = Maximum, - = Minimum. 
 
Table 3: Release parameters of Ibuprofen sustained release tablets 
 
Zero Order First order Higuchi Korsmeyer-Peppas Hixson-Crowell 
r2 ko (h
-1) r2 k1(h
-1)  r2 kH (h
-1/2) r2 n value KKP (h
-n) r2 kHC (h
-1/3) 
0.9672 4.0042 0.9933 0.1414 0.9994 17.569 0.9942 0.2465 0.4265  0.9967 0.1415 
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The rate of release calculated from Eq. 6 as 32.03 mg/h. 
Assuming that this rate of release remains constant thorough 
out the release process, the duration of release  was 
calculated as 24.97 h (similarly 23.86 h and 24.2 h for other 
two batches) by using 800mg, which was comparable to the 
required duration of  release i.e., 24h. Hence the formulation 
allows a gradual release of the active substances from the 
gel matrix. Ibuprofen diffuses through an outer gel layer 
which erodes allowing the aqueous medium to penetrate 
further into the core.  
 
The sustained absorption phase that results provides 
prolonged plasma levels of ibuprofen in the systemic 
circulation, reducing the dosage frequency normally 
required for a drug with a plasma half life of about two 
hours. The mean plasma profile of two sustained release 
800mg tablets if compared to one conventional release 
400mg tablet taken four times daily showed that the 
sustained release formulation reduced the peaks and troughs 
characteristics of the conventional release tablets. The area 
under the plasma concentration /time curve for two 
sustained release tablets was almost identical to that of four 
conventional release 400mg tablets (Data Sheet, 2005). 
 
Process validation 
Content uniformity for all the three batches was found 
within acceptable limits (95-105%). Drug content was 
measured as 96%, 99% and 102%, where it was noted that 
no significant difference was found in drug content at 85% 
and 100% for all three batches indicating that adequate 
mixing was achieved at 54min (85%) and further mixing 
may be omitted. Weight variation was found comparable for 
three batches; average weight was measured as 1.2209g, 
1.2198g and 1.2301g. The RSD for variation among 
different batches was only 0.46%. 
 
0
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Fig. 1: Drug release profile of Ibuprofen sustained release 
formulation. 
 
Reproducibility was also confirmed by comparing drug 
release profile for all three batches. Refer fig.1 for 
comparative release profile for three experimental batches. 
Duration of release was further verified and confirmed the 
accuracy and reproducibility of drug release for 24 hours. 
 
Drug release kinetics 
As shown in Fig. 2, 3, 4 and 5 plots drawn, according to 
various kinetic models, were giving linear relationship. In 
Zero order plot (fig. 2) the r2 value obtained is 0.9672 and 
first order (fig. 3) gave 0.9933 describing the drug release 
rate relationship with concentration of drug. The best 
linearity was found in Higuchi’s equation plot (fig. 4) (r2 = 
0.9994) indicating the release of drug from matrix as a 
square root of time dependent process based on Fickian 
diffusion. 
y = 4.0042x + 43.909
R2  = 0.9672
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Fig. 2:  Zero order release model of Ibuprofen sustained 
release formulation. 
 
y = -0.0614x + 1.8068
R2  = 0.9933
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Fig. 3:  First order release model of Ibuprofen sustained 
release formulation. 
 
The dissolution data was also plotted in accordance with 
Hixson Crowell cube root law (fig. 5). Applicability of data 
(r2 = 0.9967) indicates a change in surface area and diameter 
of tablets with the progressive dissolution of matrix as a 
function of time. 
 M. Harris Shoaib et al. 
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Fig. 4:  Higuchi release model of Ibuprofen sustained 
release formulation. 
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Fig. 5:  Hixson-Crowell cube root plots of Ibuprofen 
sustained release formulation. 
 
Mechanism of drug release 
By incorporating the first 60% of release data mechanism of 
release can be indicated according to Korsmeyer where n is 
the release exponent, indicative of mechanism of drug 
release. Fickian diffusional release and a case-II relaxational 
release, are the limits of this phenomenon. Fickian 
diffusional release occurs by the usual molecular diffusion 
of the drug due to a chemical potential gradient. Case-II 
relaxational release is the drug transport mechanism 
associated with stresses and state-transition in hydrophilic 
glassy polymers which swell in water or biological fluids. 
This term also includes polymer disentanglement and 
erosion (Cox et al., 1999). Table 1 describes the limits of 
this analysis for cylindrical shape, e.g. a tablet. The value of 
the release exponent in ibuprofen sustained release obtained 
as 0.2465 which as per table 1 is beyond the limits of 
Korsmeyer model so-called power law. The power law can 
only give limited insight into the exact release mechanism 
of the drug. Even if values of the exponent n are found that 
would indicate a diffusion controlled drug release 
mechanism, this is not automatically valid for HPMC 
(Siepmann and Peppas, 2001). 
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Fig. 6:  Korsmeyer – Peppas Model for mechanism of drug 
release (first 60% drug release) 
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Fig. 7:   Prediction of drug release using concentration 
(mg/L) vs. time (hr) 
 
CONCLUSION 
 
Ibuprofen sustained release matrix tablet was prepared 
successfully using HPMC as polymer to retard release and 
achieve required dissolution profile. Drug release kinetics of 
this formulation correspond best to Higuchi’s model and 
drug release mechanism as per n value of Korsmeyer & 
Peppas (Power law) can not be predicted clearly as it 
appears to be a complex mechanism of swelling, diffusion 
and erosion. 
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